Project Update

Home

Project Update

Regulus Therapeutics Inc ( RGLS )

Wednesday , Oct 22 2014

A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates
... Read more
Regulus Therapeutics Inc ( RGLS )

Wednesday , Feb 17 2016

RG-101 Interim Analysis
... Read more
Reliq Health Technologies ( RHT )

Thursday , Aug 17 2017

Reliq Health Technologies Announces Go-Live with Rio Grande Valley Health
... Read more
Remark Holdings Inc ( MARK )

Friday , Oct 13 2017

Remark Holdings' 3D Augmented Reality Chosen To Be Core Technology
... Read more
RepliCel Life Sciences Inc ( RP )

Tuesday , Apr 04 2017

Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the
... Read more
Repros Therapeutics Inc ( RPRX )

Thursday , Aug 28 2014

Androxal(R) Achieves
... Read more
Repros Therapeutics Inc ( RPRX )

Thursday , Apr 14 2016

Repros Reports Positive Clinical Data for
... Read more
Repros Therapeutics Inc ( RPRX )

Thursday , Jun 02 2016

Repros Provides Update on EU Submission of Enclomiphene for the Treatment of
... Read more
Repros Therapeutics Inc ( RPRX )

Thursday , Sep 08 2016

Repros Provides Phase 2 Results Showing Positive Outcomes for Oral
... Read more
Resverlogix Corp ( RVX )

Resverlogix Corp ( RVX )

Tuesday , Apr 07 2015

Resverlogix Receives Two
... Read more

Page 118 of 146